This is a real-world medical entrance exam question, please give the true answer based on the question and selection. Topic name: All India exam, Subject name: Pharmacology
[{'content': 'Bictegravir was approved by FDA recently for \nSelect and explain. \nA. Cystic fibrosis, B. TB, C. Hypeension, D. HIV', 'role': 'user'}, {'content': 'Answer: D \nExplanation: Bictegravir (an Integrase Inhibitor) is a component of the fixed-dose combination product bictegravir/emtricitabine/tenofovir alafenamide (brand name: Biktarvy), which received marketing approval for the treatment of HIV infection by U.S. Food and Drug Administration in February 2018.', 'role': 'assistant'}]